FPTW
ZBH icon

Franklin, Parlapiano, Turner & Welch’s Zimmer Biomet ZBH Stock Holding History

Franklin, Parlapiano, Turner & Welch’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-10
Closed -$1K – 116
2017
Q1 		$1K Hold
10
– – ﹤0.01% 125
2016
Q4 		$1K Hold
10
– – ﹤0.01% 124
2016
Q3 		$1K Hold
10
– – ﹤0.01% 162
2016
Q2 		$1K Buy
+10
New +$1.13K ﹤0.01% 114

Other funds holding ZBH

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Franklin, Parlapiano, Turner & Welch's ZBH Position: Q2 2017 in Review

Franklin, Parlapiano, Turner & Welch sold out of Zimmer Biomet (ZBH) in Q2 2017, closing a stake of 10 shares — an estimated $1K sold.

Franklin, Parlapiano, Turner & Welch first reported a position in ZBH in Q2 2016 and held it in 4 quarters. The position peaked at $1K in Q1 2017. 819 funds tracked by Wall St. Rank hold ZBH as of Q2 2017.

  • Franklin, Parlapiano, Turner & Welch reported no remaining Zimmer Biomet position as of Q2 2017 after selling out during the quarter.
  • Franklin, Parlapiano, Turner & Welch sold 10 Zimmer Biomet shares in Q2 2017, an estimated $1K.
  • Franklin, Parlapiano, Turner & Welch first reported a position in Zimmer Biomet in Q2 2016 and held it in 4 quarters.
  • Franklin, Parlapiano, Turner & Welch's Zimmer Biomet position peaked at $1K in Q1 2017.
  • 819 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2017.

Based on Franklin, Parlapiano, Turner & Welch's 13F filing for Q2 2017, filed 17 Jul 2017.